Targeted scVEGF/177Lu radiopharmaceutical inhibits growth of metastases and can be effectively combined with chemotherapy
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Blankenberg, Francis G.
Backer, Marina V.
Backer, Joseph M.
Funding for this research was provided by:
National Cancer Institute (2R44CA141806-02A1)
Text and Data Mining valid from 2016-01-16
Version of Record valid from 2016-01-16
1 December 2015
11 January 2016
16 January 2016